Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
short-term repeated dose toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP Study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1997
Report date:
1997

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
GLP compliance:
yes (incl. QA statement)
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
-
EC Number:
425-090-2
EC Name:
-
Cas Number:
86087-23-2
Molecular formula:
C4 H8 O2
IUPAC Name:
(3S)-oxolan-3-ol

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
Method of administration:
Gavage
Analytical verification of doses or concentrations:
yes
Duration of treatment / exposure:
Test duration: 28 days
Frequency of treatment:
Dosing regime: 7 days/week
No. of animals per sex per dose:
Male: 5 animals at 0 mg/kg bw/day
Male: 5 animals at 25 mg/kg bw/day
Male: 5 animals at 150 mg/kg bw/day
Male: 5 animals at 1000 mg/kg bw/day
Female: 5 animals at 0 mg/kg bw/day
Female: 5 animals at 25 mg/kg bw/day
Female: 5 animals at 150 mg/kg bw/day
Female: 5 animals at 1000 mg/kg bw/day

Results and discussion

Results of examinations

Details on results:
Clinical observations:
No deaths occurred and no signs of toxicity were observed.

Laboratory findings:
There were no toxicologically significant effects on
haematology or blood clinical chemistry.

Effects in organs:
There were no treatment related histopathological changes in
the organs examined.

Effect levels

open allclose all
Dose descriptor:
NOAEL
Effect level:
1 000 mg/kg bw/day (nominal)
Basis for effect level:
other: original NCD unit is mg/kg/day.
Dose descriptor:
NOEL
Effect level:
1 000 mg/kg bw/day (nominal)
Basis for effect level:
other: original NCD unit is mg/kg/day.

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion

Conclusions:
Administration of 1272W94 at doses up to and including 1000mg/kg/day for 28days in rats was not associated with any evident signs of toxicity
Executive summary:

Groups of five male and five female Alpk:APfSD (Wistar derived) rats were dosed orally by gavage with 0, 25, 150, 1000mg/kg/day of 1272W94 (using de-ionised water as the control substance and vehicle) for 28 consecutive days. Clinical observations, bodyweights and food consumption were measured and at the end of the scheduled period, the animals were killed and subjected to an examination post mortem. cardiac blood samples were taken for clinical pathology, selected organs were weighed and specific tissues were taken for histopathological examination. One female rat from the 1000mg/kg group was found dead on day 17 of the study but it's death was considered the result of mis-dosing. There were no clinical signs of toxicity, or any treatment related effects on bodyweight or food consumption. There were no treatment related effects on haematology or blood clinical chemistry. There were no treatment related histopathological changes in the organs examined.

Administration of 1272W94 at doses up to and including 1000mg/kg/day for 28days in rats was not associated with any evident signs of toxicity. The NOEL was determined to be >1000mg/kg/day.